Rosetta Biosoftware provides life science informatics solutions that enable breakthroughs in basic biological research, drug discovery and development, and translational medicine.
Their products accelerate research and improve safety and therapeutic decision making. We continue to innovate leading technology that converts data into understanding in support of the promise of personalized medicine.
Rosetta Biosoftware was formerly a subsidiary of Merck, and was sold to Microsoft in June 2009.
401 Terry Ave. N
Seattle, WA 98109